Intervention Review

Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis

  1. Flavio Lirussi1,*,
  2. Ezio Mastropasqua2,
  3. Serena Orando3,
  4. Rocco Orlando4

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 12 NOV 2006

DOI: 10.1002/14651858.CD005165.pub2

How to Cite

Lirussi F, Mastropasqua E, Orando S, Orlando R. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD005165. DOI: 10.1002/14651858.CD005165.pub2.

Author Information

  1. 1

    WHO Regional Office for Europe, European Office for Investment for Health and Development, Scientist, Socioeconomic Determinants of NCDs, Venice, Italy

  2. 2

    Ospedale di Este, Padova, Italy

  3. 3

    Universitá Degli Studi di Firenze, Instituto di Anestesia e Rianimazione, Firenze, Italy

  4. 4

    University of Padua Medical School, Department of Medical and Surgical Sciences, Padova, Italy

*Flavio Lirussi, Scientist, Socioeconomic Determinants of NCDs, WHO Regional Office for Europe, European Office for Investment for Health and Development, Campo Santo Stefano, San Marco 2847, Venice, I-30124, Italy. fli@ihd.euro.who.int.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

  1. Current Version

    Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis

    Flavio Lirussi, Ezio Mastropasqua, Serena Orando and Rocco Orlando

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD005165.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis

    F Lirussi, E Mastropasqua, S Orando and R Orlando

    Article first published online: 18 OCT 2006 | DOI: 10.1002/14651858.CD005165